143 related articles for article (PubMed ID: 16799654)
1. P-gp expression and Rh 123 efflux assay have no impact on survival in Egyptian pediatric acute lymphoblastic leukemia patients.
Kamel AM; El-Sharkawy N; Yassin D; Shaaban K; Hussein H; Sidhom I; Abo El-Naga S; Ameen M; El-Hattab O; Aly El-Din NH
J Egypt Natl Canc Inst; 2005 Sep; 17(3):165-72. PubMed ID: 16799654
[TBL] [Abstract][Full Text] [Related]
2. Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemia.
Ludescher C; Eisterer W; Hilbe W; Gotwald M; Hofmann J; Zabernigg A; Cianfriglia M; Thaler J
Leukemia; 1995 Feb; 9(2):350-6. PubMed ID: 7869774
[TBL] [Abstract][Full Text] [Related]
3. Assessment of P-glycoprotein expression by immunocytochemistry and flow cytometry using two different monoclonal antibodies coupled with functional efflux analysis in 34 patients with acute myeloid leukemia.
Poulain S; Lepelley P; Cambier N; Cosson A; Fenaux P; Wattel E
Adv Exp Med Biol; 1999; 457():57-63. PubMed ID: 10500780
[TBL] [Abstract][Full Text] [Related]
4. Multi-drug resistance (MDR) activity in acute leukemia determined by rhodamine 123 efflux assay.
Lamy T; Drenou B; Grulois I; Fardel O; Jacquelinet C; Goasguen J; Dauriac C; Amiot L; Bernard M; Fauchet R
Leukemia; 1995 Sep; 9(9):1549-55. PubMed ID: 7658724
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig WD
Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123
[TBL] [Abstract][Full Text] [Related]
6. [Flow cytometric analysis of P-glycoprotein function by rhodamine 123 dye-efflux assay in human leukemia cells].
Kawabata M; Kobayashi H; Mori S; Sekiguchi S; Takemura Y
Rinsho Byori; 1997 Sep; 45(9):891-8. PubMed ID: 9311264
[TBL] [Abstract][Full Text] [Related]
7. Discordance of P-glycoprotein expression and function in acute leukemia.
De Moerloose B; Dhooge C; Philippé J
Adv Exp Med Biol; 1999; 457():107-18. PubMed ID: 10500786
[TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia.
van der Kolk DM; de Vries EG; van Putten WJ; Verdonck LF; Ossenkoppele GJ; Verhoef GE; Vellenga E
Clin Cancer Res; 2000 Aug; 6(8):3205-14. PubMed ID: 10955805
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two functional flow cytometric assays to assess P-gp activity in acute leukemia.
Swerts K; de Moerloose B; Dhooge C; Noens L; Laureys G; Benoit Y; Philippé J
Leuk Lymphoma; 2004 Nov; 45(11):2221-8. PubMed ID: 15512810
[TBL] [Abstract][Full Text] [Related]
10. Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123.
Ludescher C; Thaler J; Drach D; Drach J; Spitaler M; Gattringer C; Huber H; Hofmann J
Br J Haematol; 1992 Sep; 82(1):161-8. PubMed ID: 1358171
[TBL] [Abstract][Full Text] [Related]
11. P-glycoprotein 170 expression and function as an adverse independent prognostic factor in childhood acute lymphoblastic leukemia.
Casale F; D'Angelo V; Addeo R; Caraglia M; Crisci S; Rondelli R; Di Tullio MT; Indolfi P
Oncol Rep; 2004 Dec; 12(6):1201-7. PubMed ID: 15547738
[TBL] [Abstract][Full Text] [Related]
12. P-glycoprotein and terminal transferase expression identify prognostic subsets within cytogenetic risk classes in acute myeloid leukemia.
Del Poeta G; Venditti A; Stasi R; Aronica G; Cox MC; Buccisano F; Tamburini A; Bruno A; Maurillo L; Battaglia A; Suppo G; Epiceno AM; Del Moro B; Masi M; Amadori S; Papa G
Leuk Res; 1999 May; 23(5):451-65. PubMed ID: 10374859
[TBL] [Abstract][Full Text] [Related]
13. Assays for the analysis of P-glycoprotein in acute myeloid leukemia and CD34 subsets of AML blasts.
Sonneveld P; Wiemer E
Leukemia; 1997 Jul; 11(7):1160-5. PubMed ID: 9205006
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of rhodamine-efflux and MDR-1/P-170 expression in childhood acute leukemia.
Tafuri A; Sommaggio A; Burba L; Albergoni MP; Petrucci MT; Mascolo MG; Testi AM; Basso G
Leuk Res; 1995 Dec; 19(12):927-31. PubMed ID: 8632662
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of P-glycoprotein (P-gp) expression in childhood acute lymphoblastic leukemia. Results of a 6-year prospective study.
Dhooge C; De Moerloose B
Adv Exp Med Biol; 1999; 457():11-9. PubMed ID: 10500775
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogenetics.
Wuchter C; Karawajew L; Ruppert V; Büchner T; Schoch C; Haferlach T; Ratei R; Dörken B; Ludwig WD
Leukemia; 1999 Dec; 13(12):1943-53. PubMed ID: 10602414
[TBL] [Abstract][Full Text] [Related]
17. Study of expression and functional activity of P-GP membrane glycoprotein in children with acute leukemia.
Shman TV; Savitskii VP; Potapnev MP; Aleinikova OV
Bull Exp Biol Med; 2006 Jun; 141(6):727-30. PubMed ID: 17364061
[TBL] [Abstract][Full Text] [Related]
18. Evidence of a role for functional heterogeneity in multidrug resistance transporters in clinical trials of P-glycoprotein modulation in acute myeloid leukemia.
Marcelletti JF; Sikic BI; Cripe LD; Paietta E
Cytometry B Clin Cytom; 2019 Jan; 96(1):57-66. PubMed ID: 30334334
[TBL] [Abstract][Full Text] [Related]
19. Multifactorial drug-resistance phenomenon in acute leukemias: impact of P170-MDR1, LRP56 protein, glutathione-transferases and metallothionein systems on clinical outcome.
Goasguen JE; Lamy T; Bergeron C; Ly Sunaram B; Mordelet E; Gorre G; Dossot JM; Le Gall E; Grosbois B; Le Prisé PY; Fauchet R
Leuk Lymphoma; 1996 Nov; 23(5-6):567-76. PubMed ID: 9031088
[TBL] [Abstract][Full Text] [Related]
20. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]